Drug intelligence / Profile preview

BP22042013 (Spanish Foundation for Neurometrics)

Development stage
Unknown
Lead developer
Spanish Foundation for Neurometrics
Administration
Oral
01

Overview

BP22042013 is an investigational dietary intervention identifier used in the clinical trial NCT02614599, titled 'Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein (BrainProtein).' Sponsored by the Spanish Foundation for Neurometrics Development, it refers to a high-protein dietary supplement regimen evaluated for its potential to improve neurocognitive and neurobiological outcomes in children aged 7–12 diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder (ADD). The intervention is compared against a low-carbohydrate diet over a three-month period, with researchers measuring changes in brain connectivity via EEG and event-related potentials (ERP), as well as behavioral improvements. The regimen aims to leverage nutritional therapy to modulate brain function and behavior in pediatric populations.

Other names
BrainProtein

Beyond the preview

Go deeper on BP22042013 (Spanish Foundation for Neurometrics).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BP22042013 (Spanish Foundation for Neurometrics).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call